Evodiamine suppresses non-small cell lung cancer by elevating CD8+ T cells and downregulating the MUC1-C/PD-L1 axis.
J Exp Clin Cancer Res. 2020 Nov 19;39(1):249. doi: 10.1186/s13046-020-01741-5.
J Exp Clin Cancer Res. 2020.
PMID: 33208183
Free PMC article.